Comparason of extraction methods for PCR detection of Burkholderia cepacia complex (BCC) from cystic fibrosis patients

被引:2
|
作者
Ergunay, Koray [1 ]
Yurdakul, Pinar [1 ]
Sener, Burcin [1 ]
Ozcelik, Ugur [2 ,3 ]
Karabulut, Erdem [4 ]
Kiper, Nural [2 ,3 ]
机构
[1] Hacettepe Univ, Fac Med, Dept Microbiol & Clin Microbiol, TR-06100 Ankara, Turkey
[2] Hacettepe Univ, Fac Med, Dept Pediat, Div Chest Dis, TR-06100 Ankara, Turkey
[3] Ihsan Dogramaci Childrens Hosp, TR-06100 Ankara, Turkey
[4] Hacettepe Univ, Fac Med, Dept Biostat, TR-06100 Ankara, Turkey
来源
CENTRAL EUROPEAN JOURNAL OF MEDICINE | 2008年 / 3卷 / 02期
关键词
DNA extraction; PCR; Burkholderia; Burkholderia cepacia complex; cystic fibrosis;
D O I
10.2478/s11536-007-0069-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Direct detection of Burkholderia cepacia complex (BCC) and its genomovars from sputum by molecular tests emerges as a method for rapid identification. In this study, four DNA extraction methods were evaluated forth e identification for BCC from sputum of CF patients. Sputa from 28 CF patients were aliquoted and spiked with BCC reference strain. Boiling, phenol-chloroform, CTAB methods and a commercial spin column kit was used for DNA extraction. Total DNA yields were determined by spectrophotometry and single-round recA PCR was used for detection of BCC. No significant difference was observed in DNA yields from different extraction methods. Lower limit of detection for recA PCR was determined as 10(6) cfu/ml. Amplification was observed in 7/16 (43.7%) of sputa for boiling, 8/16 (50%) of sputa for GTAB and 13/16 (81.2%) of sputa for phenol-chloroform method and spin column kit in the assay sensitivity range determined in the study. Phenol-chloroform and commercial spin column kit were found to be better suited for DNA purification from sputum of CF patients for BCC identification. Diagnostic impact of single-round recA PCR directly from sputum was limited to chronically-infected patients.
引用
收藏
页码:157 / 162
页数:6
相关论文
共 50 条
  • [41] Burkholderia cepacia:: dangers of a phytopathogen organism for patients with cystic fibrosis
    Segonds, C
    Chabanon, G
    ANNALES DE BIOLOGIE CLINIQUE, 2001, 59 (03) : 259 - 269
  • [42] Genomovar Diversity Amongst Burkholderia cepacia Complex Isolates From an Australian Adult Cystic Fibrosis Unit
    T. J. Kidd
    S. C. Bell
    C. Coulter
    European Journal of Clinical Microbiology and Infectious Diseases , 2003, 22 : 434 - 437
  • [43] Evolving epidemiology of Pseudomonas aerugincisa and the Burkholderia cepacia complex in cystic fibrosis lung infection
    Govan, John R. W.
    Brown, Alan R.
    Jones, Andrew M.
    FUTURE MICROBIOLOGY, 2007, 2 (02) : 153 - 164
  • [44] Infection with Burkholderia cepacia complex bacteria and pulmonary exacerbations of cystic fibrosis
    Denis, Melissa St.
    Ramotar, Karam
    Vandemheen, Katherine
    Tullis, Elizabeth
    Ferris, Wendy
    Chan, Francis
    Lee, Craig
    Slinger, Robert
    Aaron, Shawn D.
    CHEST, 2007, 131 (04) : 1188 - 1196
  • [45] In Vitro Susceptibility of Burkholderia cepacia Complex Isolated from Cystic Fibrosis Patients to Ceftazidime-Avibactam and Ceftolozane-Tazobactam
    Van Dalem, A.
    Herpol, M.
    Echahidi, F.
    Peeters, C.
    Wybo, I.
    De Wachter, E.
    Vandamme, P.
    Pierard, D.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (09)
  • [46] Prevalence of Burkholderia cepacia complex species in cystic fibrosis patients in Argentina during the period 2011-2015
    Cipolla, Lucia
    Rocca, Florencia
    Martinez, Claudia
    Aguerre, Lorena
    Barrios, Ruben
    Prieto, Monica
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2018, 36 (07): : 431 - 434
  • [47] Burkholderia cepacia complex nasal isolation in immunocompetent patients with sinonasal polyposis not associated with cystic fibrosis
    G. Marioni
    R. Rinaldi
    C. Staffieri
    G. Ottaviano
    R. Marchese-Ragona
    L. Giacomelli
    S. M. Ferraro
    A. Staffieri
    European Journal of Clinical Microbiology & Infectious Diseases, 2007, 26 : 73 - 75
  • [48] Is prolonged incubation required for optimal recovery of Burkholderia cepacia complex in sputum from cystic fibrosis patients? Data versus dogma
    Naqvi, Syeda
    Varadhan, Hemalatha
    Givney, Rodney
    PATHOLOGY, 2020, 52 (03) : 366 - 369
  • [49] Burkholderia cepacia complex nasal isolation in immunocompetent patients with sinonasal polyposis not associated with cystic fibrosis
    Marioni, G.
    Rinaldi, R.
    Staffieri, C.
    Ottaviano, G.
    Marchese-Ragona, R.
    Giacomelli, L.
    Ferraro, S. M.
    Staffieri, A.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2007, 26 (01) : 73 - 75
  • [50] Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex -: Survival linked to genomovar type
    Aris, RM
    Routh, JC
    LiPuma, JJ
    Heath, DG
    Gilligan, PH
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (11) : 2102 - 2106